BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The 8th Annual Immuno-Oncology 360° Delivers Three Key Benefit
 s:\n\n- Access to KOLs driving the science- Partnership opportunities wit
 h all stakeholders in Immuno-Oncology- Presentations on the latest data i
 mpacting the science\, clinical and business advancements in Immuno-Oncol
 ogy\n\n2022 Key Topic Areas- Discovery/Preclinical Science- Cell and Gene
  Therapy- Translational Science- Bispecifics- Clinical Developments- Neoa
 djuvant/Adjuvant Data- Emerging Biomarkers- Cytokines- Clinical Operation
 s- IO Combinations- Imaging Advancements- Business Developments\n\nImmuno
 -Oncology 360° reports on the most current data and rapid advancements to
  help IO stakeholders:- Be at the forefront of the most relevant research
  and developments from key leadership who are at the pulse of cancer immu
 notherapy- Foster collaboration amongst those working in all aspects of c
 ancer immunotherapy together under one roof- Partner to expand technology
  platforms to develop therapeutics at an accelerated rate- Receive the la
 test pre-clinical\, translational and clinical data from academia and ind
 ustry- Create and prioritize strategies targeted toward specific tumor ty
 pes- Identify and gain a greater understanding of what assets are availab
 le for potential combinations- Hear from IO clinical trial leaders as the
 y cover trial design\, clinical operations\, the latest outcomes and less
 ons learned- Get key investor and analyst evaluations and insights on the
  IO landscape\, challenges and what's next- Learn about biomarker advance
 ments in vaccines\, imaging\, neoantigen approaches and more- Obtain cove
 rage on a wide range of emerging technologies\n
DTEND:20220318T160000
DTSTAMP:20260307T144802Z
DTSTART:20220316T073000
LOCATION:New York Marriott at the Brooklyn Bridge\, 333\, Adams Street\, B
 rooklyn\, New York\, 11201\,
SEQUENCE:0
SUMMARY:The 8th Annual Immuno-Oncology 360° Delivers Three Key Benefits:\n
 - Access to KOLs driving the science- Partnership opportunities with all 
 stakehol...
UID:be8c3c02-c184-4a00-bada-a1487aad0dff
END:VEVENT
END:VCALENDAR